CELL
Baillie Gifford & Co’s PhenomeX Inc. Common Stock CELL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-603,544
| Closed | -$296K | – | 301 |
|
2023
Q2 | $296K | Sell |
603,544
-743,338
| -55% | -$364K | ﹤0.01% | 283 |
|
2023
Q1 | $1.56M | Sell |
1,346,882
-419
| -0% | -$486 | ﹤0.01% | 259 |
|
2022
Q4 | $3.61M | Sell |
1,347,301
-2,370,899
| -64% | -$6.35M | ﹤0.01% | 251 |
|
2022
Q3 | $10.6M | Buy |
3,718,200
+39,216
| +1% | +$112K | 0.01% | 209 |
|
2022
Q2 | $18.3M | Buy |
3,678,984
+139,078
| +4% | +$691K | 0.02% | 195 |
|
2022
Q1 | $25.2M | Buy |
3,539,906
+211,420
| +6% | +$1.5M | 0.02% | 199 |
|
2021
Q4 | $60.5M | Buy |
3,328,486
+392,452
| +13% | +$7.13M | 0.03% | 172 |
|
2021
Q3 | $57.4M | Buy |
2,936,034
+703,456
| +32% | +$13.8M | 0.03% | 178 |
|
2021
Q2 | $100M | Buy |
2,232,578
+1,113,235
| +99% | +$49.9M | 0.05% | 153 |
|
2021
Q1 | $56.2M | Buy |
1,119,343
+342,283
| +44% | +$17.2M | 0.03% | 175 |
|
2020
Q4 | $69.5M | Buy |
777,060
+171,717
| +28% | +$15.4M | 0.04% | 148 |
|
2020
Q3 | $46.2M | Buy |
+605,343
| New | +$46.2M | 0.03% | 156 |
|